AstraZeneca posts strong rise in profits, optimistic about sales
11993
Anglo-Swedish drugs giant AstraZeneca reported a 14 percent rise in third quarter pre-tax profit and said it was on track to hit earnings estimates for the full year.
423299
U.S. stocks rose on Friday as a report showing stronger-than-expected job growth boosted optimism about the outlook for profits.
346082
Eli Lilly and Co  on Tuesday said fourth-quarter profit rose on lower taxes and better-than-expected sales of its medicines, including its newer treatments for depression, diabetes and cancer.
393883
Schering continues its strong sales and earnings growth.
218452
The drug maker said net income rose 6 percent to $926.3 million and it raised its outlook for the year.
477244
Pfizer Inc. PFE.N, the world's  biggest drugmaker, on Wednesday said third-quarter earnings  rose on higher sales of key medicines and favorable foreign  exchange factors.
641779
Schering-Plough Corp.  on  Monday reported quarterly earnings far higher than Wall Street  expected, fueled by growing demand for its drugs against  cholesterol, arthritis, allergies and hepatitis C.
553993
The company said quarterly profit would be higher than analystsâ estimates and it raised its full-year outlook as exchange rates and price and volume increases offset high commodity costs.
280767
Quarterly profit beat expectations on strong growth in its international, ground and freight segments.
120706
Merck & Co  on Monday said its third-quarter profit rose sharply, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast in view of strong current trends.
420770
Strong sales of new vaccines and treatments help US drugs group Merck unveil a sharp rise in quarterly profits.
620048
Anglo-Swedish pharmaceutical giant AstraZeneca PLC announced a 51 percent leap in third-quarter profits Thursday, despite an &#36;80 million loss on the U.S. rejection of its anti-clotting drug Exanta.
551035
Merck & Co. on Monday said second-quarter earnings rose on higher sales of its new vaccines and medicines, and the company raised its 2007 profit forecast amid continuing strong demand for the medicines.
229274
Genentech, the biotechnology company, posted a 41 percent increase in second-quarter profit on sales of its cancer drugs, continuing a positive earnings streak.
48474
Microsoft reported quarterly sales and profit gains that surpassed Wall Streetâs expectations, and delivered an optimistic outlook.
434444
Walgreen Co , one of the  largest U.S. drugstore operators, said on Friday quarterly  profit rose a better-than-expected 5.5 percent, helped by  higher sales and cost controls.
2963
U.S. drug benefit manager Medco Health Solutions Inc.  on Wednesday reported a higher-than-expected quarterly profit on strong demand for mail-delivered generic medicines and raised its 2007 outlook, sending its shares up more than 11 percent to an all-time high.